ALECTINIB SECRETS

The safety and efficacy of erlotinib have not been recognized for individuals with NSCLC whose tumors clearly show other EGFR mutations. Moreover it is not encouraged to be used together with platinum-based chemotherapy. LabelChance Summary There isn't any info on the presence of erlotinib in human milk, or the results of erlotinib on the breastfed